Correlation Between GlaxoSmithKline PLC and New Perspective
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and New Perspective at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and New Perspective into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and New Perspective Fund, you can compare the effects of market volatilities on GlaxoSmithKline PLC and New Perspective and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of New Perspective. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and New Perspective.
Diversification Opportunities for GlaxoSmithKline PLC and New Perspective
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between GlaxoSmithKline and NEW is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and New Perspective Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New Perspective and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with New Perspective. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New Perspective has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and New Perspective go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and New Perspective
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the New Perspective. In addition to that, GlaxoSmithKline PLC is 1.95 times more volatile than New Perspective Fund. It trades about -0.31 of its total potential returns per unit of risk. New Perspective Fund is currently generating about 0.02 per unit of volatility. If you would invest 6,091 in New Perspective Fund on August 26, 2024 and sell it today you would earn a total of 16.00 from holding New Perspective Fund or generate 0.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. New Perspective Fund
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| New Perspective |
GlaxoSmithKline PLC and New Perspective Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and New Perspective
The main advantage of trading using opposite GlaxoSmithKline PLC and New Perspective positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, New Perspective can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New Perspective will offset losses from the drop in New Perspective's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| New Perspective vs. Franklin Emerging Market | New Perspective vs. Shelton Emerging Markets | New Perspective vs. Origin Emerging Markets | New Perspective vs. Rbc Bluebay Emerging |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |